VEGFA and hepatocellular carcinoma: As previously described, the circulating VEGF levels increased after the TACE procedure [14]; we found that high baseline VEGF (>131.09 pg/mL) was an independent prognostic factor for poor survival in HCC patients treated with TACE, which corroborated the above views.